Absolute Pro 1012538-60Recalls & reported problems
Abbott Vascular Inc. · Absolute Pro Vascular Self-Expanding Stent System 10.0 mm x 60 mm x 135 cm / Over-The-Wire · Class 3 · Implant
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648176296), received between Sep 14, 2017 and Sep 10, 2024 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Premature Activation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Premature Activation2
- Difficult or Delayed Activation1
- Difficult or Delayed Positioning1
- Difficult to Remove1
- Failure to Advance1
- Material Deformation1
- Material Separation1
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Foreign Body In Patient1
- No Consequences Or Impact To Patient1
- No Patient Involvement1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjurySep 10, 2024Stretched; Material Deformation; Stretched; Material Deformation
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE AV FISTULA. THE 10X60MM ABS PRO SELF EXPANDING STENT SYSTEM (SESS) WAS IMPLANTED AT THE TARGET LESION WITHOUT ISSUE. HOWEVER, AFTER POST DILATATION THE STENT APPEARED TO HAVE SLIGHTLY ELONGATED AND A BUCKLE APPEARED AT A TURN IN THE ARTERY WALL AT A SIDE BRANCH AT THE TARGET LESION. ALTHOUGH, THERE WAS NO ISSUE WITH FLOW OR PATIENT EFFECT, OUT PRECAUTION THE PHYSICIAN DECIDED TO IMPLANT A COVERED STENT IN THE MIDDLE OF THE IMPLANTED ABS PRO STENT TO ENSURE THE STENT WAS ADHERED TO THE VESSEL. THERE WAS NO ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20185353 ↗MalfunctionMar 26, 2024Difficult to Remove; Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking; Difficult to Remove; Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking
SUBSEQUENT TO THE INITIALLY FILED MEDWATCH REPORT, ADDITIONAL INFORMATION WAS RECEIVED. IT WAS REPORTED THAT DURING RETRACTION OF THE SES, THE TIP SEPARATED AND BECAME LODGED IN THE SHEATH. THE SEPARATED TIP WAS REMOVED WITH THE SHEATH AND GUIDE WIRE. NO ADDITIONAL INFORMATION WAS PROVIDED..
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18977818 ↗MalfunctionDec 30, 2019Premature Activation; Failure to Advance; Premature Activation; Failure to Advance
IT WAS REPORTED THAT THE 10 X 60 MM ABSOLUTE PRO VASCULAR STENT WAS UNABLE TO CROSS THE MODERATELY CALCIFIED LESION IN THE SUPERFICIAL FEMORAL ARTERY. DURING REMOVAL OF THE SELF-EXPANDING STENT SYSTEM (SESS), SOME OF THE STENT BECAME PARTIALLY DEPLOYED/FLOWERED. NO ATTEMPT HAD BEEN MADE TO DEPLOY THE STENT AS IT HAD NOT REACHED THE TARGET LESION. THE PHYSICIAN WAS ABLE TO NORMALLY REMOVE THE SESS ALONG WITH THE PARTIALLY DEPLOYED STENT. ANOTHER STENT WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9530409 ↗MalfunctionNov 4, 2019Premature Activation; Premature Activation
IT WAS REPORTED THAT THE STENT OF A 10X60MM ABSOLUTE PRO SELF-EXPANDING STENT SYSTEM (SESS) WAS UNSHEATHED/EXPOSED TO THE SHEATH WHEN REMOVED FROM THE PACKAGING. THE SESS WAS NOT USED AND THERE WAS NO PATIENT INVOLVEMENT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH A NEW 10X60MM ABSOLUTE PRO SESS. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 9273880 ↗InjurySep 14, 2017Difficult or Delayed Positioning
IT WAS REPORTED THAT THE 10 X 60 MM ABSOLUTE PRO VASCULAR STENT SYSTEM WAS ADVANCED TO THE MILDLY TORTUOUS LEFT COMMON ILIAC ARTERY AND WAS READY FOR STENT DEPLOYMENT, BUT RESISTANCE WAS FELT WITH THE THUMBWHEEL AFTER THE FIRST QUARTER OR HALF TURN OF THE THUMBWHEEL. TROUBLESHOOTING STEPS WERE PERFORMED TO DEPLOY THE STENT, BUT RESISTANCE WAS FELT WITH THE THUMBWHEEL. THE STENT WAS DEPLOYED IN THE NON-TARGET EXTERNAL ILIAC INSTEAD OF THE INTENDED COMMON ILIAC ARTERY. A SECOND SAME SIZE ABSOLUTE PRO VASCULAR STENT WAS SUCCESSFULLY DEPLOYED IN THE TARGET LESION WITHOUT ISSUE. THERE WAS NO REPORTED ADVERSE PATIENT SEQUELA OR A CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Foreign Body In Patient
MAUDE report 6867255 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Omnilink Elite 1012631-59Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.